Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Although soluble suppression of tumorigenicity 2 (sST2) in serum is known to be associated with ischemic heart disease and heart failure, data regarding its prognostic impact in ST-segment elevation myocardial infarction (STEMI) is limited. We evaluated the prognostic impacts of serum sST2 and other...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5552027?pdf=render |
| _version_ | 1818478129294868480 |
|---|---|
| author | Jongwook Yu Pyung Chun Oh Minsu Kim Jeonggeun Moon Yae Min Park Kyounghoon Lee Soon Yong Suh Seung Hwan Han Kyunghee Byun Taehoon Ahn Woong Chol Kang |
| author_facet | Jongwook Yu Pyung Chun Oh Minsu Kim Jeonggeun Moon Yae Min Park Kyounghoon Lee Soon Yong Suh Seung Hwan Han Kyunghee Byun Taehoon Ahn Woong Chol Kang |
| author_sort | Jongwook Yu |
| collection | DOAJ |
| description | Although soluble suppression of tumorigenicity 2 (sST2) in serum is known to be associated with ischemic heart disease and heart failure, data regarding its prognostic impact in ST-segment elevation myocardial infarction (STEMI) is limited. We evaluated the prognostic impacts of serum sST2 and other serum biomarkers in STEMI patients undergoing primary percutaneous coronary intervention (PCI).Consecutive all 323 patients with STEMI that underwent primary PCI were enrolled. Blood tests and samples were obtained in an emergency room. The primary endpoint was 1-year major adverse cardiovascular and cerebrovascular events (MACCEs), defined as a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and ischemia-driven revascularization.Mean age was 59.1±13.1 years (men 84%). MACCE (20 cardiovascular deaths, 7 non-fatal MI, 4 non-fatal stroke, 7 ischemia-driven revascularizations) occurred in 38 patients (12%). After adjusting for confounding factors, Cox regression analysis revealed that high serum sST2 (>75.8 ng/mL mean value, adjusted hazard ratio 2.098, 95% CI 1.008-4.367, p = 0.048) and high serum NT-proBNP level (>400 pg/mL, adjusted hazard ratio 2.606, 95% CI 1.086-6.257, p = 0.032) at the time of presentation independently predicted MACCE within a year of primary PCI. Furthermore, when high serum sST2 level was combined with high serum NT-proBNP level, the hazard ratio of MACCE was highest (adjusted hazard ratio 7.93, 95% CI 2.97-20.38, p<0.001).Elevated serum levels of sST2 or NT-proBNP at the time of presentation were found to predict 1-year MACCE independently and elevated serum levels of sST2 plus NT-proBNP were associated with even poorer prognosis in patients with STEMI undergoing primary PCI. |
| first_indexed | 2024-12-10T09:44:27Z |
| format | Article |
| id | doaj.art-0816101daacf424293e5230304124e92 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T09:44:27Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-0816101daacf424293e5230304124e922022-12-22T01:53:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018282910.1371/journal.pone.0182829Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.Jongwook YuPyung Chun OhMinsu KimJeonggeun MoonYae Min ParkKyounghoon LeeSoon Yong SuhSeung Hwan HanKyunghee ByunTaehoon AhnWoong Chol KangAlthough soluble suppression of tumorigenicity 2 (sST2) in serum is known to be associated with ischemic heart disease and heart failure, data regarding its prognostic impact in ST-segment elevation myocardial infarction (STEMI) is limited. We evaluated the prognostic impacts of serum sST2 and other serum biomarkers in STEMI patients undergoing primary percutaneous coronary intervention (PCI).Consecutive all 323 patients with STEMI that underwent primary PCI were enrolled. Blood tests and samples were obtained in an emergency room. The primary endpoint was 1-year major adverse cardiovascular and cerebrovascular events (MACCEs), defined as a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and ischemia-driven revascularization.Mean age was 59.1±13.1 years (men 84%). MACCE (20 cardiovascular deaths, 7 non-fatal MI, 4 non-fatal stroke, 7 ischemia-driven revascularizations) occurred in 38 patients (12%). After adjusting for confounding factors, Cox regression analysis revealed that high serum sST2 (>75.8 ng/mL mean value, adjusted hazard ratio 2.098, 95% CI 1.008-4.367, p = 0.048) and high serum NT-proBNP level (>400 pg/mL, adjusted hazard ratio 2.606, 95% CI 1.086-6.257, p = 0.032) at the time of presentation independently predicted MACCE within a year of primary PCI. Furthermore, when high serum sST2 level was combined with high serum NT-proBNP level, the hazard ratio of MACCE was highest (adjusted hazard ratio 7.93, 95% CI 2.97-20.38, p<0.001).Elevated serum levels of sST2 or NT-proBNP at the time of presentation were found to predict 1-year MACCE independently and elevated serum levels of sST2 plus NT-proBNP were associated with even poorer prognosis in patients with STEMI undergoing primary PCI.http://europepmc.org/articles/PMC5552027?pdf=render |
| spellingShingle | Jongwook Yu Pyung Chun Oh Minsu Kim Jeonggeun Moon Yae Min Park Kyounghoon Lee Soon Yong Suh Seung Hwan Han Kyunghee Byun Taehoon Ahn Woong Chol Kang Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. PLoS ONE |
| title | Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. |
| title_full | Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. |
| title_fullStr | Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. |
| title_full_unstemmed | Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. |
| title_short | Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP. |
| title_sort | improved early risk stratification of patients with st segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble st2 and nt probnp |
| url | http://europepmc.org/articles/PMC5552027?pdf=render |
| work_keys_str_mv | AT jongwookyu improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT pyungchunoh improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT minsukim improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT jeonggeunmoon improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT yaeminpark improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT kyounghoonlee improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT soonyongsuh improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT seunghwanhan improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT kyungheebyun improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT taehoonahn improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp AT woongcholkang improvedearlyriskstratificationofpatientswithstsegmentelevationmyocardialinfarctionundergoingprimarypercutaneouscoronaryinterventionusingacombinationofserumsolublest2andntprobnp |